ImmunoGen, Inc. has announced that its platinum-resistant ovarian cancer drug ELAHERE (mirvetuximab soravtansine-gynx) has been granted FDA accelerated approval. This first FDA antibody-drug ...

He covers the gamut of gadgets and is a notable reviewer of mobile accessories and portable audio products, including headphones and speakers. He's also an e-reader and e-publishing expert as well ...

Beyond cases, there's also the vibrant ecosystem of iPhone accessories, updated for the 2024 models to give you faster wireless charging, high-quality audio on the go, keep you fit and connected ...

That candidate hits the same target as Elahere, the ADC that AbbVie acquired in its $10 billion takeover of ImmunoGen. Elahere received full FDA approval in ovarian cancer this year, but ...

Now, Lenovo just announced a new line of official Legion Go accessories to make the handheld even better. This includes a hard carrying case, USB Type-C docking station, and even an accessory to ...

And feather headbands and accessories are a special way to usher in some glam before the holidays come around.” Whether you tie your ribbons in bows or opt for a pre-tied barrette, Reed says ...

It's now called PlayStation Accessories and it lets you customize your DualSense Edge controller's button layouts, stick sensitivity, and more directly on your PC. The biggest single new feature ...

Monitor for ocular toxicity and withhold, reduce, or permanently discontinue ELAHERE based on severity and persistence of ocular adverse reactions. Pneumonitis Severe, life-threatening, or fatal ...

Full data from the primary analysis of the positive, single-arm Phase 2 PICCOLO trial, evaluating mirvetuximab soravtansine (ELAHERE®), for high folate receptor-alpha (FRα) expressing platinum ...

Elahere (mirvetuximab soravtansine) was approved by the FDA for the treatment of platinum-resistant ovarian cancer. In the trial that supported its approval, approximately 30% of patients responded to ...